Tesis
Alpha 7-nAChRs as a Novel Therapeutic Target in HIV-gp120 Neurotoxicity: Implications in the Development of HIV-associated Neurocognitive Disorders.
Autor
Capó Vélez, Coral M.
Lasalde-Dominicci, José A. (Consejero)
Institución
Resumen
The syndrome of cognitive and motor dysfunction observed after infection with HIV-1
has been designated HIV-1 associated neurocognitive disorder (HAND) (Antinori et al.,
2007). The neuropathology associated with HAND includes encephalitis, microglial
activation, chronic inflammation, neuronal loss, and decreased synaptic density (Garden
et al., 2002). However, no effective treatment has been developed since the mechanisms
leading to these cognitive deficiencies are not clearly understood. Various mechanisms
have been proposed to explain these deficits, and implicate the HIV-1 coat protein, gp120
as an important factor mediating injury in the brain (Lipton, 1998). HIV-gp120 can act
directly on neurons to induce neurotoxicity and apoptosis, and it can also activate the
release of cytokines and cytotoxic factors (Bachis et al., 2006). Furthermore, it can bind
and activate various receptors in the central nervous system (CNS) such as CD4, CXCR4,
CCR5, and nicotinic acetylcholine receptors (Bracci et al., 1992; Liu et al., 2000; Rock et
al., 2008). Nicotinic acetylcholine receptors have various subtypes, several of which are
expressed in the CNS. The homopentameric receptor α7 (α7-nAChR) is widely
expressed throughout the CNS and has been shown to help control cognitive functions
(Court et al., 2000; Gahring and Rogers, 2005). This receptor is also associated with other
neurocognitive diseases such as Alzheimer and Parkinson’s, and even though its role in
HAND has been suggested (Bracci et al., 1992; Giunta et al., 2004; Rock et al., 2008), it
has not been elucidated until recently in a study by Ballester et al., 2012. The purpose of
this dissertation is to study the role of α7-nAChRs on gp120-neurotoxicity using an in
vivo model. Chapter 2 recapitulates findings from a study on an in vitro setting (Ballester
et al., 2012), where we described a model to account for the gp120-neurotoxity based on the regulation of α7-nAChRs. Additionally, the use of the gp120-transgenic mice (gp120-
tg), an in vivo model, to study this mechanism was also demonstrated. Since α7-nAChR
are highly permeable to calcium, we hypothesized that activation of the receptor on
upregulated cells would lead to higher calcium concentrations sufficient to trigger
apoptosis, results described on Chapter 3. Lastly, on Chapter 4 we studied gp120-tg
performance on paradigms dependent on striatal function to correlate neuronal damage
with behavioral changes. We demonstrate that gp120-tg do exhibit both locomotor and
cognitive deficits. Moreover, treatment with antagonist of α7-nAChRs improved
locomotor deficiencies on gp120-tg mice. We conclude with the statement that the α7-
nAChR upregulation is a model to account for neurodegeneration in the brain,
summarized on Chapter 5 and future perspectives and directions for this dissertation are
detailed on Chapter 6.